Detalhe da pesquisa
1.
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.
Clin Infect Dis
; 65(3): 510-513, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28419210